Good morning, everyone. We're here today to continue the study of the decision of Atomic Energy of Canada Limited and the government to discontinue the MAPLE reactors project, and its ramifications on the supply of isotopes.
We have as witnesses today, from MDS Nordion, Steve West, president; and Grant Malkoske, vice-president of strategic technologies. At the table we also have John Campion. He is legal counsel and will not answer questions. We have as an individual John Waddington, nuclear safety consultant.
I believe we have one presentation from each group. From MDS Nordion, Steve West is giving the presentation.
Go ahead please, sir, for up to ten minutes.